year
hundr
million
peopl
afflict
respiratori
tract
infect
caus
wide
rang
virus
case
respiratori
viral
infect
asymptomat
rel
mild
caus
minor
ill
patient
fulli
recov
seriou
ill
develop
especi
among
certain
highrisk
group
lead
hospit
worsen
chronic
condit
even
death
case
moder
sever
respiratori
tract
infect
patient
seek
outpati
medic
attent
refer
medic
attend
acut
respiratori
infect
ari
infect
frequent
result
lost
product
form
work
school
absente
reduc
product
due
attend
work
school
sick
presente
common
virus
associ
respiratori
tract
infect
human
adenoviru
adno
human
coronaviru
cov
human
metapneumoviru
hmpv
human
rhinoviru
hrv
influenza
viru
influenza
parainfluenza
viru
piv
respiratori
syncyti
viru
rsv
viral
pathogen
vari
pathogenesi
epidemiolog
tempor
appear
throughout
year
typic
share
common
set
symptom
includ
cough
fever
rhinorrhea
among
mani
viral
ari
seen
primari
care
year
portion
routin
test
determin
offend
organ
rapid
test
differenti
among
virus
readili
avail
ii
avail
treatment
respiratori
virus
chiefli
palli
except
antivir
treatment
influenza
new
assay
method
use
multiplex
revers
transcriptas
polymeras
chain
reaction
mrtpcr
becom
avail
allow
rel
rapid
detect
multipl
viru
type
influenza
season
multicent
us
influenza
vaccin
effect
flu
network
conduct
studi
design
determin
effect
season
influenza
vaccin
studi
use
singleplex
rtpcr
srtpcr
detect
influenza
viru
univers
pittsburgh
site
flu
network
also
use
mrtpcr
purpos
studi
compar
agreement
srtpcr
mrtpcr
influenza
viru
detect
ii
examin
distribut
virus
associ
ari
visit
januari
april
allegheni
counti
pennsylvania
use
mrtpcr
iii
compar
person
characterist
symptom
among
infect
variou
virus
studi
among
first
examin
wide
rang
respiratori
viral
infect
includ
four
cov
four
piv
result
outpati
primari
care
visit
among
individu
across
broad
age
spectrum
particip
individu
enrol
univers
pittsburgh
site
flu
studi
fund
center
diseas
control
prevent
cdc
describ
purpos
parent
studi
determin
effect
season
influenza
vaccin
use
test
neg
studi
proport
vaccin
among
test
posit
influenza
compar
proport
vaccin
among
test
neg
elig
criteria
includ
age
month
present
one
particip
primari
care
center
treatment
upper
respiratori
ill
day
durat
cough
fever
take
influenza
antivir
oseltamivir
zanamivir
medic
visit
emerg
depart
visit
includ
elig
individu
provid
written
inform
consent
complet
enrol
survey
swab
nasal
oropharyng
sampl
influenza
vaccin
statu
combin
electron
medic
record
emr
data
selfreport
influenza
activ
increas
appreci
baselin
level
determin
local
surveil
system
midjanuari
pittsburgh
region
henc
studi
enrol
began
januari
end
april
prospect
studi
approv
univers
pittsburgh
institut
review
board
patient
except
infant
year
sampl
two
polyest
swab
remel
one
nasal
oropharyng
mucosa
infant
sampl
nasal
swab
swab
combin
cryovial
courier
upmc
clinic
virolog
laboratori
specimen
store
lysi
buffer
aliquot
nucleic
acid
isol
detect
influenza
viru
use
cdc
srtpcr
test
mrtpcr
test
use
esensor
instrument
respiratori
viral
panel
genmark
diagnost
fund
avail
analyz
specimen
parent
studi
mrtpcr
specimen
posit
influenza
srtpcr
select
allow
comparison
mrtpcr
assay
identifi
coinfect
influenza
srtpcr
influenzaposit
specimen
suffici
sampl
mrtpcr
test
addit
influenzaneg
specimen
suffici
sampl
select
total
ari
specimen
isol
viral
nucleic
acid
control
materi
patient
specimen
perform
use
easymag
autom
extractor
biomerieux
durham
nc
usa
previous
describ
srtpcr
previous
publish
virusspecif
primer
probe
nucleotid
sequenc
use
detect
influenza
b
viru
detect
perform
use
abi
realtim
pcr
instrument
appli
biosystem
foster
citi
ca
usa
esensor
rvp
multiplex
pcr
assay
genmark
diagnost
carlsbad
ca
usa
use
studi
current
approv
clinic
use
europ
methodolog
characterist
broader
rang
viral
analyt
us
fda
approv
version
nucleic
acid
extract
srtpcr
assay
addit
bacteriophag
intern
control
includ
esensor
rvp
kit
specimen
immedi
prior
extract
specimen
test
esensor
instrument
respiratori
viral
panel
accord
manufactur
instruct
publish
panel
includ
adenoviru
adno
group
b
c
e
coronavirus
cov
season
influenza
viru
includ
subtyp
determin
influenza
b
viru
hmpv
piv
type
rsv
type
b
hrv
particip
complet
survey
enrol
age
race
person
household
smoke
statu
household
composit
asthma
diagnosi
exercis
influenza
vaccin
statu
symptom
ari
selfreport
overal
health
ari
subject
social
statu
selfreport
health
day
enrol
determin
bodi
mass
index
bmi
calcul
selfreport
height
weight
reduc
number
small
cell
size
combin
similar
virus
eg
cov
combin
cov
singl
virus
viru
group
detect
sampl
use
analys
final
six
group
viru
detect
hrv
cov
rsv
hmpv
influenza
viru
type
measur
agreement
singleplex
multiplex
influenza
assay
determin
use
cohen
kappa
statist
descript
statist
present
mean
standard
deviat
continu
variabl
percentag
discret
variabl
particip
divid
three
age
group
children
year
young
adult
year
older
adult
year
bivari
multinomi
regress
model
use
assess
associ
patient
characterist
result
mrtpcr
probabl
distribut
outcom
variabl
consist
two
group
depend
variabl
viru
group
independ
variabl
particip
person
characterist
determin
independ
effect
multinomi
regress
model
fit
variabl
control
age
selfreport
health
statu
viru
detect
refer
group
discret
characterist
two
level
statist
signific
adjust
analysi
pairwis
multinomi
regress
model
fit
assess
associ
level
bonferroni
correct
use
adjust
multipl
comparison
overal
effect
age
group
signific
p
analys
pairwis
comparison
differ
age
group
conduct
determin
pair
age
group
effect
depend
variabl
analys
conduct
use
sa
version
sa
institut
inc
cari
nc
usa
ensur
compar
srtpcr
mrtpcr
influenza
outcom
agreement
analys
conduct
influenza
b
case
n
identifi
influenza
b
strain
report
togeth
signific
agreement
influenza
result
assay
chisquar
p
confid
limit
sensit
specif
srtpcr
treat
gold
standard
singleplex
influenza
posit
multiplex
influenza
posit
influenza
influenza
b
multiplex
neg
viru
multiplex
posit
noninfluenza
virus
hrv
mhmpv
rsv
cycl
threshold
ct
valu
mrtpcr
influenzaneg
srtpcr
influenzaposit
sampl
three
mrtpcr
neg
influenza
posit
virus
ct
valu
comparison
purpos
mean
ct
valu
mrtpcr
influenza
posit
standard
deviat
multiplex
assay
identifi
influenza
posit
detect
singleplex
rtpcr
influenza
codetect
rsv
codetect
mhmpv
cov
discord
influenza
posit
distribut
nearli
equal
among
age
group
young
adult
children
older
adult
concord
age
group
high
among
ari
patient
test
posit
singl
viru
infect
test
posit
one
viru
ie
codetect
neg
test
virus
distribut
singl
viru
infect
codetect
shown
number
codetect
repres
virus
detect
number
patient
virus
frequent
codetect
hrv
cov
occurr
follow
influenza
adno
rsv
hmpv
piv
percentag
singl
multipl
virus
detect
vari
age
children
percentag
singl
viru
multipl
virus
viru
detect
respect
wherea
young
adult
percentag
older
adult
percentag
respect
p
data
shown
among
sampl
week
distribut
viral
infect
vari
week
p
shown
overal
cov
infect
readili
appar
late
januari
earli
march
rsv
activ
januari
februari
hrv
infect
increas
april
hmpv
infect
vari
time
period
influenza
infect
peak
march
late
histor
light
season
show
demograph
ill
characterist
patient
five
viru
group
includ
coinfect
viru
detect
mean
age
selfrat
health
statu
bmi
differ
significantli
across
viru
categori
selfreport
cough
fever
sore
throat
nasal
congest
enrol
significantli
frequent
among
viral
infect
viru
detect
adjust
multinomi
regress
analys
type
viru
infect
significantli
differ
age
group
bmi
presenc
fever
nasal
congest
children
like
hmpv
rsv
detect
older
adult
young
adult
less
like
hmpv
rsv
influenza
virus
detect
older
adult
present
fever
like
hmpv
influenza
viral
infect
present
nasal
congest
like
cov
hrv
viral
infect
individu
influenza
cov
higher
bmi
type
infect
although
overal
influenza
vaccin
statu
differ
across
viral
etiolog
vaccin
influenza
like
rsv
viru
detect
compar
vaccin
proport
report
cough
wheez
sore
throat
differ
significantli
across
viral
infect
cough
like
report
hmpv
hrv
rsv
infect
wheez
like
hmpv
rsv
infect
sore
throat
less
like
report
hmpv
infect
one
viru
detect
like
young
vaccin
influenza
lower
bmi
present
singl
viral
infect
studi
offer
data
viral
infect
associ
outpati
ari
us
winter
influenza
season
use
esensor
viru
panel
current
avail
europ
panel
virus
expand
version
includ
sever
virus
part
fdaclear
format
four
cov
four
piv
test
involv
bioelectron
detect
viral
dna
amplifi
nucleic
acid
extract
specimen
convent
rtpcr
assay
compar
favor
singleplex
rtpcr
test
characterist
albeit
predomin
strain
year
test
yield
littl
inform
studi
limit
includ
coverag
singl
season
influenza
notabl
light
pittsburgh
predomin
inabl
test
inclus
sampl
ari
specimen
mrtpcr
howev
sampl
size
suffici
allow
confid
relationship
characterist
ari
case
virus
associ
time
period
addit
viral
panel
contain
bacteria
mycoplasma
possibl
respiratori
virus
virus
could
occur
frequent
season
use
multiplex
rtpcr
threefifth
medic
attend
outpati
visit
acut
respiratori
ill
winter
associ
viral
etiolog
virus
differ
distribut
across
age
group
selfreport
health
statu
bmi
presenc
fever
nasal
congest
coinfect
present
small
proport
case
vari
age
weight
influenza
vaccin
statu
